Skip to content

Bjain Omeo Anemia Syrup in patients with Anemia

A pilot study to evaluate the efficacy of Bjain Omeo Anemia Syrup in patients with Anemia - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/077400
Enrollment
6
Registered
2024-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Bjain Omeo Anemia Syrup: Test Product: Bjain Omeo Anemia Syrup, Dose: Syrup (2tsp BD) orally twice a day for the durationof 60 days. Route of administration: Oral, Duration: 60 days C

Sponsors

BJAIN PHARMACEUTICALS Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects of either gender- male or female of age 18-55. 2.Healthy subjects with reported diet deficient Anemia of any grade - Mild: Hemoglobin 10.0 g/dL to lower limit of normal. Moderate: Hemoglobin 8.0 to 10.0 g/dL. Severe: Hemoglobin 6.5 to 7.9 g/dL 3. Having signed a Consent Form. 4.Should be able to read and write (in English, Hindi or local language). 5. Having valid proof of identity and age.

Exclusion criteria

Exclusion criteria: 1. Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2. Having refused to give her assent by not signing the consent form 2. Taking part in another study liable to interfere with this study 2. Anemia related to any known Chronic disease 3. Having cutaneous hypersensitivity 4. Following a chronic or intermittent medicinal treatment comprising any of the following products: aspirin-based products, anti inflammatories, anti-histamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 5. Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months

Design outcomes

Primary

MeasureTime frame
1, % Change in Hemoglobin 2. % Change in Serum IronTimepoint: Day 0, Day 30, day 60

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026